EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Effects of Ferric Derisomaltose in Heart Failure with Iron Deficiency according to Renal Function in the IRONMAN Randomised Controlled Trial

Fozia Z Ahmed, Paul R Kalra, John G F Cleland, Abdallah Al-Mohammad, Andrew L Clark, Victor K S Chong, Alan G Japp, Rebecca E Lane, Stephen J Leslie, Iain C Macdougall, Thuraia Nageh, Rajiv Sankaranarayanan und 7 weitere

American Journal of Nephrology · 2025

DOI: 10.1159/000547121 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift American Journal of Nephrology, 2025. Verfasst von Fozia Z Ahmed und 18 weiteren Autor:innen. Beteiligte Einrichtung: Keele University, Keele Cardiovascular Research Group, Keele, UK. Hauptthemen laut MEDLINE: Heart Failure, Ferric Compounds, Anemia, Iron-Deficiency, Maltose. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

For heart failure (HF) with iron deficiency (ID), the benefits of intravenous iron might differ according to kidney function.

Methods

IRONMAN was a randomised, open-label trial of intravenous ferric derisomaltose (FDI) versus usual care (UC) in patients with HF, left ventricular ejection fraction ≤45%, and ID (transferrin saturation

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureFerric CompoundsAnemia, Iron-DeficiencyMaltoseHumansGlomerular Filtration RateMaleFemaleAgedMiddle AgedTreatment OutcomeHospitalizationStroke VolumeDisaccharides

Stichwörter der Autor:innen

Glomerular filtration rateHeart failureIron deficiencyOutcomesRenal function

Substanzen

Ferric Compoundsferric derisomaltoseMaltoseDisaccharides

Autor:innen und Institutionen

  • Keele University, Keele Cardiovascular Research Group, Keele, UK.
  • Department of Cardiology, Manchester University NHS Foundation Trust, Manchester, UK.
  • School of Cardiovascular and Metabolic Health, University of Glasgow, British Heart Foundation Cardiovascular Research Centre, Glasgow, UK.
  • University of Sheffield, Department of Infection, Immunity and Cardiovascular Disease, Sheffield, UK.
  • Hull University Teaching Hospitals NHS Trust, Castle Hill Hospital, Cottingham, UK.
  • Department of Cardiology, University Hospital Crosshouse, Kilmarnock, UK.

Förderung

  • British Heart Foundation

Zitieren

APA

Ahmed, F. Z., Kalra, P. R., Cleland, J. G. F., Al-Mohammad, A., Clark, A. L., Chong, V. K. S., Japp, A. G., Lane, R. E., Leslie, S. J., Macdougall, I. C., Nageh, T., Sankaranarayanan, R., Sobolewska, J., Wong, A., Thomson, E. A., Petrie, M. C., Squire, I. B., Ford, I., & Kalra, P. A. (2025). Effects of Ferric Derisomaltose in Heart Failure with Iron Deficiency according to Renal Function in the IRONMAN Randomised Controlled Trial. American Journal of Nephrology. https://doi.org/10.1159/000547121

Vancouver

Ahmed FZ, Kalra PR, Cleland JGF, Al-Mohammad A, Clark AL, Chong VKS, et al. Effects of Ferric Derisomaltose in Heart Failure with Iron Deficiency according to Renal Function in the IRONMAN Randomised Controlled Trial. American Journal of Nephrology. 2025. doi:10.1159/000547121

BibTeX
@article{Ahmed2025,
  author = {Ahmed, Fozia Z and Kalra, Paul R and Cleland, John G F and Al-Mohammad, Abdallah and Clark, Andrew L and Chong, Victor K S and Japp, Alan G and Lane, Rebecca E and Leslie, Stephen J and Macdougall, Iain C and Nageh, Thuraia and Sankaranarayanan, Rajiv and Sobolewska, Jolanta and Wong, Aaron and Thomson, Elizabeth A and Petrie, Mark C and Squire, Iain B and Ford, Ian and Kalra, Philip A},
  title = {Effects of Ferric Derisomaltose in Heart Failure with Iron Deficiency according to Renal Function in the IRONMAN Randomised Controlled Trial},
  journal = {American Journal of Nephrology},
  year = {2025},
  doi = {10.1159/000547121}
}
Kostenlos starten →